The structure and function of the glucagon-like peptide-1 receptor and its ligands

被引:211
|
作者
Donnelly, Dan [1 ]
机构
[1] Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England
关键词
GLP-1; GPCR; exendin-4; exenatide; liraglutide; diabetes; glucagon; insulin; VASOACTIVE-INTESTINAL-PEPTIDE; GUINEA-PIG PANCREAS; N-TERMINAL DOMAIN; GLP-1; 7-36; AMIDE; IN-VITRO; INSULIN-SECRETION; DISPERSED ACINI; EXTRACELLULAR DOMAIN; PARATHYROID-HORMONE; BIOLOGICAL-ACTIVITY;
D O I
10.1111/j.1476-5381.2011.01687.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glucagon-like peptide-1(7-36)amide (GLP-1) is a 30-residue peptide hormone released from intestinal L cells following nutrient consumption. It potentiates the glucose-induced secretion of insulin from pancreatic beta cells, increases insulin expression, inhibits beta-cell apoptosis, promotes beta-cell neogenesis, reduces glucagon secretion, delays gastric emptying, promotes satiety and increases peripheral glucose disposal. These multiple effects have generated a great deal of interest in the discovery of long-lasting agonists of the GLP-1 receptor (GLP-1R) in order to treat type 2 diabetes. This review article summarizes the literature regarding the discovery of GLP-1 and its physiological functions. The structure, function and sequenceactivity relationships of the hormone and its natural analogue exendin-4 (Ex4) are reviewed in detail. The current knowledge of the structure of GLP-1R, a Family B GPCR, is summarized and discussed, before its known interactions with the principle peptide ligands are described and summarized. Finally, progress in discovering non-peptide ligands of GLP-1R is reviewed. GLP-1 is clearly an important hormone linking nutrient consumption with blood sugar control, and therefore knowledge of its structure, function and mechanism of action is of great importance.
引用
收藏
页码:27 / 41
页数:15
相关论文
共 50 条
  • [21] Obesity and Glucagon-Like Peptide-1 Receptor Agonists
    Celletti, Francesca
    Branca, Francesco
    Farrar, Jeremy
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (07): : 561 - 562
  • [22] Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists
    Khan, Sadiya S.
    Ndumele, Chiadi E.
    Kazi, Dhruv S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (02): : 113 - 114
  • [23] Glucagon-Like Peptide-1 Receptor: A Novel Receptor in Platelets
    Kahal, Hassan
    Aburima, Ahmed
    Spurgeon, Benjamin
    Wraith, Katie S.
    Ghavideldarestani, Maryam
    Rizvi, Faran
    Sturmey, Roger G.
    Kilpatrick, Eric S.
    Atkin, Stephen L.
    Naseem, Khalid M.
    DIABETES, 2015, 64 : A528 - A528
  • [24] Impact of glucagon-like peptide-1 on endothelial function
    Sjoholm, A.
    DIABETES OBESITY & METABOLISM, 2009, 11 : 19 - 25
  • [25] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
    De Block, Christophe E. M.
    Dirinck, Eveline
    Verhaegen, Ann
    Van Gaal, Luc F.
    DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 788 - 805
  • [26] Immunocharacterization and function of glucagon-like peptide-1 islet receptor in syrian hamster
    Boissard, C
    LeclercqMeyer, V
    Pessah, M
    Garel, JM
    Rosselin, G
    Malaisse, WJ
    DIABETOLOGIA, 1997, 40 : 496 - 496
  • [27] Glucagon-Like Peptide-1 and its Cardiovascular Effects
    Kyung-Sun Heo
    Keigi Fujiwara
    Jun-ichi Abe
    Current Atherosclerosis Reports, 2012, 14 : 422 - 428
  • [28] Differential Activation and Modulation of the Glucagon-Like Peptide-1 Receptor by Small Molecule Ligands
    Wootten, Denise
    Savage, Emilia E.
    Willard, Francis S.
    Bueno, Ana B.
    Sloop, Kyle W.
    Christopoulos, Arthur
    Sexton, Patrick M.
    MOLECULAR PHARMACOLOGY, 2013, 83 (04) : 822 - 834
  • [29] Glucagon-Like Peptide-1 and its Cardiovascular Effects
    Heo, Kyung-Sun
    Fujiwara, Keigi
    Abe, Jun-ichi
    CURRENT ATHEROSCLEROSIS REPORTS, 2012, 14 (05) : 422 - 428
  • [30] STRUCTURE/ACTIVITY CHARACTERIZATION OF GLUCAGON-LIKE PEPTIDE-1
    GALLWITZ, B
    WITT, M
    PAETZOLD, G
    MORYSWORTMANN, C
    ZIMMERMANN, B
    ECKART, K
    FOLSCH, UR
    SCHMIDT, WE
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 225 (03): : 1151 - 1156